These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1936894)

  • 1. Evaluation of the effect of aldose reductase inhibition on increased basement membrane collagen fluorescence in diabetic rats.
    Cohen MP; Klepser H; Wu VY
    Gen Pharmacol; 1991; 22(4):603-6. PubMed ID: 1936894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats.
    Suárez G; Rajaram R; Bhuyan KC; Oronsky AL; Goidl JA
    J Clin Invest; 1988 Aug; 82(2):624-7. PubMed ID: 3136193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sorbinil on glomerular structure and function in long-term-diabetic rats.
    Mauer SM; Steffes MW; Azar S; Brown DM
    Diabetes; 1989 Jul; 38(7):839-46. PubMed ID: 2525493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
    Craven PA; DeRubertis FR
    Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
    Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
    Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A; Ku L; Cohen MP
    Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal and microvascular effects of an aldose reductase inhibitor in experimental diabetes. Biochemical, functional and ultrastructural studies.
    Kassab JP; Guillot R; Andre J; Claperon N; Bellon G; Feldmann G; Peyroux J; Sternberg M
    Biochem Pharmacol; 1994 Aug; 48(5):1003-8. PubMed ID: 8093087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aldose reductase, glomerular metabolism, and diabetic nephropathy.
    Cohen MP
    Metabolism; 1986 Apr; 35(4 Suppl 1):55-9. PubMed ID: 3007926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diabetes and Sorbinil treatment on phospholipid metabolism in rat glomeruli.
    Cohen MP; Klepser H; Cua E
    Biochim Biophys Acta; 1986 Apr; 876(2):226-32. PubMed ID: 3006784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-lysine reduces nonenzymatic glycation of glomerular basement membrane collagen and albuminuria in diabetic rats.
    Jyothirmayi GN; Modak R; Reddi AS
    Nephron; 2001 Feb; 87(2):148-54. PubMed ID: 11244310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorbinil prevents glomerular hyperperfusion in diabetic rats.
    Bank N; Mower P; Aynedjian HS; Wilkes BM; Silverman S
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
    J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A; Frank RN; Zhang NL; Samadani E
    Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sorbinil does not prevent galactose-induced glomerular capillary basement membrane thickening in the rat.
    Das A; Frank RN; Zhang NL
    Diabetologia; 1990 Sep; 33(9):515-21. PubMed ID: 2123806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular Na+-K+-ATPase activity in acute and chronic diabetes and with aldose reductase inhibition.
    Cohen MP; Klepser H
    Diabetes; 1988 May; 37(5):558-62. PubMed ID: 2834250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldose reductase inhibition, glomerular metabolism, and diabetic nephropathy.
    Cohen M
    Diabet Med; 1985 May; 2(3):203-6. PubMed ID: 3032499
    [No Abstract]   [Full Text] [Related]  

  • 17. Aldose reductase activity and basement membrane thickening.
    Frank RN
    Metabolism; 1986 Apr; 35(4 Suppl 1):35-40. PubMed ID: 3083207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH; Ross IS
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undersulfation of glomerular basement membrane heparan sulfate in experimental diabetes and lack of correction with aldose reductase inhibition.
    Cohen MP; Klepser H; Wu VY
    Diabetes; 1988 Oct; 37(10):1324-7. PubMed ID: 2970980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular basement membrane thickening in streptozotocin diabetic rats despite treatment with an aldose reductase inhibitor.
    Osterby R; Gundersen HJ
    J Diabet Complications; 1989; 3(3):149-53. PubMed ID: 2528558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.